Skip to content

China Nuokang Bio-Pharmaceutical Inc.

Delisted

CIK 1474952fmd_0EVBZ6WCFP5MA80QP2668SQXJ5Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Dec 31, 2011, 3 periods

Latest annual · FY2011

Millions
Total revenues
288
Gross profit
250
Operating income
19
Net income
(14)
Free cash flow
25
Open Financials

China Nuokang Bio-Pharmaceutical Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
RevenueCN¥288.3 millionCN¥315.8 million-8.7%20-F/A 2012-05-15 · proof
Gross profitCN¥249.8 millionCN¥278.5 million-10.3%20-F/A 2012-05-15 · proof
Operating incomeCN¥18.7 millionCN¥65.9 million-71.7%20-F/A 2012-05-15 · proof
Net income-CN¥14 millionCN¥46.1 million-130.4%20-F/A 2012-05-15 · proof
Cash from operating activitiesCN¥82.1 million-CN¥21.2 million20-F/A 2012-05-15 · proof
Free cash flowCN¥25 million-CN¥53.9 million20-F/A 2012-05-15 · proof
Total assetsCN¥702.3 millionCN¥744.9 million-5.7%20-F/A 2012-05-15 · proof
Total liabilitiesCN¥87.5 millionCN¥107.1 million-18.3%20-F/A 2012-05-15 · proof
Cash and cash equivalentsCN¥179.4 millionCN¥191.8 million-6.5%20-F/A 2012-05-15 · proof
Total debtCN¥19.9 millionCN¥58.3 million-65.8%20-F/A 2012-05-15 · proof
What was China Nuokang Bio-Pharmaceutical Inc.'s revenue in fiscal 2011?
China Nuokang Bio-Pharmaceutical Inc. reported revenue of CN¥288.3 million for fiscal 2011 (the year ended Dec 31, 2011), against CN¥315.8 million the year before (-8.7%). Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What was China Nuokang Bio-Pharmaceutical Inc.'s gross profit in fiscal 2011?
China Nuokang Bio-Pharmaceutical Inc. reported gross profit of CN¥249.8 million for fiscal 2011 (the year ended Dec 31, 2011), against CN¥278.5 million the year before (-10.3%). Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What was China Nuokang Bio-Pharmaceutical Inc.'s operating income in fiscal 2011?
China Nuokang Bio-Pharmaceutical Inc. reported operating income of CN¥18.7 million for fiscal 2011 (the year ended Dec 31, 2011), against CN¥65.9 million the year before (-71.7%). Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What was China Nuokang Bio-Pharmaceutical Inc.'s net income in fiscal 2011?
China Nuokang Bio-Pharmaceutical Inc. reported net income of -CN¥14 million for fiscal 2011 (the year ended Dec 31, 2011), against CN¥46.1 million the year before (-130.4%). Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What was China Nuokang Bio-Pharmaceutical Inc.'s cash from operating activities in fiscal 2011?
China Nuokang Bio-Pharmaceutical Inc. reported cash from operating activities of CN¥82.1 million for fiscal 2011 (the year ended Dec 31, 2011), against -CN¥21.2 million the year before. Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What was China Nuokang Bio-Pharmaceutical Inc.'s free cash flow in fiscal 2011?
China Nuokang Bio-Pharmaceutical Inc. reported free cash flow of CN¥25 million for fiscal 2011 (the year ended Dec 31, 2011), against -CN¥53.9 million the year before. Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What are China Nuokang Bio-Pharmaceutical Inc.'s total assets?
As of Dec 31, 2011, China Nuokang Bio-Pharmaceutical Inc. reported total assets of CN¥702.3 million, against CN¥744.9 million a year earlier (-5.7%). Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What are China Nuokang Bio-Pharmaceutical Inc.'s total liabilities?
As of Dec 31, 2011, China Nuokang Bio-Pharmaceutical Inc. reported total liabilities of CN¥87.5 million, against CN¥107.1 million a year earlier (-18.3%). Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What are China Nuokang Bio-Pharmaceutical Inc.'s cash and cash equivalents?
As of Dec 31, 2011, China Nuokang Bio-Pharmaceutical Inc. reported cash and cash equivalents of CN¥179.4 million, against CN¥191.8 million a year earlier (-6.5%). Source: the 20-F/A filed with the SEC on May 15, 2012. SEC
What is China Nuokang Bio-Pharmaceutical Inc.'s total debt?
As of Dec 31, 2011, China Nuokang Bio-Pharmaceutical Inc. reported total debt of CN¥19.9 million, against CN¥58.3 million a year earlier (-65.8%). Source: the 20-F/A filed with the SEC on May 15, 2012. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1474952&period_type=annual&limit=5"

Information only, not investment advice.